{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:38:08Z","timestamp":1775155088541,"version":"3.50.1"},"reference-count":100,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Endometrial cancer is one of the most common gynecological malignancies, yet the molecular mechanisms that lead to tumor development and progression are still not fully established. Matrix metalloproteinases (MMPs) are a group of enzymes that play an important role in carcinogenesis. They are proteases involved in the degradation of the extracellular matrix (ECM) that surrounds the tumor and the affected tissue allows cell detachment from the primary tumor causing local invasion and metastasis formation. Recent investigations demonstrate significantly increased metalloproteinase and metalloproteinase inhibitor levels in patients with endometrial cancer compared to those with normal endometrium. In this review, we aim to show their clinical significance and possible use in the diagnosis and treatment of patients with endometrial cancer. We have critically summarized and reviewed the research on the role of MMPs in endometrial cancer.<\/jats:p>","DOI":"10.3390\/ijms222212472","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T02:43:09Z","timestamp":1637289789000},"page":"12472","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metalloproteinases in Endometrial Cancer\u2014Are They Worth Measuring?"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-681X","authenticated-orcid":false,"given":"Kaja","family":"Michalczyk","sequence":"first","affiliation":[{"name":"Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneta","family":"Cymbaluk-P\u0142oska","sequence":"additional","affiliation":[{"name":"Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Al. Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Ewald","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/path.1400","article-title":"Extracellular matrix remodelling: The role of matrix metalloproteinases","volume":"200","author":"Stamenkovic","year":"2003","journal-title":"J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2010","journal-title":"FEBS J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Quintero-Fabi\u00e1n, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J.C., Arana-Arg\u00e1ez, V., Lara-Riegos, J., Ram\u00edrez-Camacho, M.A., and Alvarez-S\u00e1nchez, M.E. (2019). Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01370"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y99-055","article-title":"Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis","volume":"77","author":"Forget","year":"1999","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_7","unstructured":"(2021, September 20). Uterine Cancer. Cancer Stat Facts 2020, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"ref_9","first-page":"63","article-title":"An update of the classical Bokhman\u2019s dualistic model of endometrial cancer","volume":"15","author":"Danielska","year":"2016","journal-title":"Prz. Menopauzal."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II Endometrial Cancers: Have They Different Risk Factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2016.12.010","article-title":"Bokhman Redux: Endometrial cancer \u201ctypes\u201d in the 21st century","volume":"144","author":"Suarez","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Getz","year":"2013","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0625.2003.120201.x","article-title":"Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer","volume":"12","year":"2003","journal-title":"Exp. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix Metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/carcin\/bgx063","article-title":"Matrix metalloproteinases: Their functional role in lung cancer","volume":"38","author":"Merchant","year":"2017","journal-title":"Carcinog"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2337\/diabetes.51.4.1093","article-title":"Modulation of Adipose Tissue Expression of Murine Matrix Metalloproteinases and Their Tissue Inhibitors with Obesity","volume":"51","author":"Maquoi","year":"2002","journal-title":"Diabetes"},{"key":"ref_19","first-page":"389","article-title":"Post-transcriptional regulation of MMP16 and TIMP2 expression via miR-382, miR-410 and miR-200b in endometrial cancer","volume":"14","author":"Rak","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Schr\u00f6pfer, A., Kammerer, U., Kapp, M., Dietl, J., Feix, S., and Anacker, J. (2010). Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-553"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0090-8258(03)00077-5","article-title":"Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer","volume":"89","author":"Tunuguntla","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1023039230052","article-title":"MT1-MMP and MMP-7 in invasion and metastasis of human cancers","volume":"22","author":"Shiomi","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Liu, C., Li, Y., Hu, S., Chen, Y., Gao, L., Liu, D., Guo, H., and Yang, Y. (2018). Clinical significance of matrix metalloproteinase-2 in endometrial cancer: A systematic review and meta-analysis. Medicine, 97.","DOI":"10.1097\/MD.0000000000010994"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0009-8981(01)00679-9","article-title":"Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood","volume":"314","author":"Jung","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.2016.127","article-title":"Levels of matrix metalloproteinases differ in plasma and serum\u2014Aspects regarding analysis of biological markers in cancer","volume":"115","author":"Jonsson","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/dmm009","article-title":"Estrogen and the endometrium: Lessons learned from gene expression profiling in rodents and human","volume":"13","author":"Groothuis","year":"2007","journal-title":"Hum. Reprod. Update"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway with Several Open Questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm. Cancer"},{"key":"ref_28","first-page":"7677","article-title":"Uterine Adenocarcinoma in Mice following Developmental Treatment with Estrogens: A Model for Hormonal Carcinogenesis","volume":"50","author":"Newbold","year":"1990","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1210\/jc.2005-2748","article-title":"Mechanisms of irregular bleeding with hormone therapy: The role of matrix metalloproteinases and their tissue inhibitors","volume":"91","author":"Hickey","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Critchley, H.O., Kelly, R.W., Baird, D.T., and Brenner, R.M. (2006). Regulation of human endometrial function: Mechanisms relevant to uterine bleeding. Reprod. Biol. Endocrinol., 4.","DOI":"10.1186\/1477-7827-4-S1-S5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1095\/biolreprod64.5.1285","article-title":"Cyclic changes in the matrix metalloproteinase system in the ovary and uterus","volume":"64","author":"Curry","year":"2001","journal-title":"Biol. Reprod."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.fertnstert.2008.12.142","article-title":"Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding","volume":"93","author":"Zhang","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1995-7645(13)60146-7","article-title":"Estrogen up-regulates MMP2\/9 expression in endometrial epithelial cell via VEGF-ERK1\/2 pathway","volume":"6","author":"Shan","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ygyno.2004.05.024","article-title":"Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer","volume":"94","author":"Pilka","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_35","first-page":"1379","article-title":"Presence of Estrogen Receptor \u03b2 in the Human Endometrium through the Cycle: Expression in Glandular, Stromal, and Vascular Cells1","volume":"86","author":"Lecce","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0301-2115(00)00554-6","article-title":"Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle","volume":"98","author":"Mertens","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880062","article-title":"Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the Literature","volume":"13","author":"Kounelis","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF02966446","article-title":"Relevance of ER to the development of endometrial hyperplasia and adenocarcinoma","volume":"6","author":"Kato","year":"1999","journal-title":"Breast Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem-38-3-476","article-title":"Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age","volume":"38","author":"Hemsell","year":"1974","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00001648-200203000-00013","article-title":"Physical activity, body mass index, and ovulatory disorder infertility","volume":"13","author":"Spiegelman","year":"2002","journal-title":"Epidemiology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Silvestris, E., De Pergola, G., Rosania, R., and Loverro, G. (2018). Obesity as disruptor of the female fertility. Reprod. Biol. Endocrinol., 16.","DOI":"10.1186\/s12958-018-0336-z"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Deng, Y., Zhang, Y., Li, S., Zhou, W., Ye, L., Wang, L., Tao, T., Gu, J., Yang, Z., and Zhao, D. (2017). Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-14534-2"},{"key":"ref_43","first-page":"219","article-title":"Matrix Metalloproteinase-2 and -9 Levels in Obese Patients","volume":"5","author":"Derosa","year":"2008","journal-title":"Endothel. J. Endothel. Cell Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1515\/BC.2008.110","article-title":"Cancer cells, adipocytes and matrix metalloproteinase 11: A vicious tumor progression cycle","volume":"389","author":"Motrescu","year":"2008","journal-title":"Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11888","DOI":"10.1074\/jbc.M209196200","article-title":"Matrix Metalloproteinases Are Differentially Expressed in Adipose Tissue during Obesity and Modulate Adipocyte Differentiation","volume":"278","author":"Chavey","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03032599","article-title":"The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis","volume":"7","author":"John","year":"2001","journal-title":"Pathol. Oncol. Res."},{"key":"ref_48","first-page":"1408","article-title":"The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bilyk, O., Coatham, M., Jewer, M., and Postovit, L.-M. (2017). Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00145"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/humupd\/dmy035","article-title":"The role of mesenchymal\u2013epithelial transition in endometrial function","volume":"25","author":"Krishnamoorthy","year":"2019","journal-title":"Hum. Reprod. Update"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1096\/fj.201701382RR","article-title":"EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression","volume":"32","author":"Chatterjee","year":"2018","journal-title":"FASEB J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature03688","article-title":"Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability","volume":"436","author":"Radisky","year":"2005","journal-title":"Nature"},{"key":"ref_53","first-page":"604","article-title":"Expression of matrix metalloproteinase-2,9 and it\u2019s tissue inhibitor-1,2 in endometrial carcinoma","volume":"37","author":"Guo","year":"2002","journal-title":"Zhonghua Fuchanke Zazhi"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/cncr.10355","article-title":"Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion","volume":"94","author":"Misajon","year":"2002","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/annonc\/mdj129","article-title":"Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: A clinical-pathological correlation study","volume":"17","author":"Graesslin","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2004.06.028","article-title":"Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer\u2014MMP-9 correlates to the grade and the stage","volume":"94","author":"Aglund","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.2910580518","article-title":"Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor","volume":"58","author":"Naito","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_58","first-page":"4726","article-title":"Matrix Metalloproteinase Inhibitor BB-94 (Batimastat) Inhibits Human Colon Tumor Growth and Spread in a Patient-like Orthotopic Model in Nude Mice","volume":"54","author":"Wang","year":"1994","journal-title":"Cancer Res."},{"key":"ref_59","first-page":"2815","article-title":"Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)","volume":"56","author":"Eccles","year":"1996","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ijc.2910580326","article-title":"Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor","volume":"58","author":"Chirvi","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.2147\/OTT.S136840","article-title":"Quercetin inhibits epithelial\u2013mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells","volume":"10","author":"Yu","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial\u2013mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/cvr\/cvt060","article-title":"An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo","volume":"99","author":"Fang","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.RES.0000260801.12916.b5","article-title":"Mechanisms Underlying the Impairment of Ischemia-Induced Neovascularization in Matrix Metalloproteinase 2\u2013Deficient Mice","volume":"100","author":"Cheng","year":"2007","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","article-title":"Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation","volume":"179","author":"Bekes","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1073\/pnas.0706438104","article-title":"Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis","volume":"104","author":"Ardi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbamcr.2009.09.017","article-title":"Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions","volume":"1803","author":"Deryugina","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1074\/jbc.M112.417451","article-title":"Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells","volume":"288","author":"Mazor","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fphar.2011.00111","article-title":"MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis","volume":"2","author":"Sounni","year":"2011","journal-title":"Front. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cr.1998.17","article-title":"Complex role of matrix metalloproteinases in angiogenesis","volume":"8","author":"Sang","year":"1998","journal-title":"Cell Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1055-9965.EPI-08-1184","article-title":"The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors","volume":"18","author":"Clements","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2559.2007.02612.x","article-title":"The role of matrix metalloproteinases-2, -7 and -9 and \u03b2-catenin in high grade endometrial carcinoma","volume":"50","author":"Monaghan","year":"2007","journal-title":"Histopathology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2362.1999.00532.x","article-title":"Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma","volume":"29","author":"Iurlaro","year":"1999","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1136\/ijgc-00009577-200609000-00029","article-title":"Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions","volume":"16","author":"Graesslin","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_78","first-page":"2715","article-title":"High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma","volume":"28","author":"Honkavuori","year":"2008","journal-title":"Anticancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<470::AID-IJC4>3.0.CO;2-D","article-title":"Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas","volume":"84","author":"Ueno","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_80","first-page":"470","article-title":"Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis","volume":"16","author":"Misugi","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"ref_81","first-page":"4391","article-title":"Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer","volume":"19","author":"Moser","year":"1999","journal-title":"Anticancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cymbaluk-P\u0142oska, A., Chudecka-G\u0142az, A., Pius-Sadowska, E., Sompolska-Rzechu\u0142a, A., Chudecka, K., Bulsa, M., Machali\u0144ski, B., and Menkiszak, J. (2017). Clinical Relevance of NGAL\/MMP-9 Pathway in Patients with Endometrial Cancer. Dis. Markers, 2017.","DOI":"10.1155\/2017\/6589262"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2012\/269279","article-title":"Abnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancer","volume":"32","author":"Yu","year":"2012","journal-title":"Dis. Markers"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/37995","article-title":"Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1","volume":"389","author":"Maskos","year":"1997","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.1999.tb07675.x","article-title":"Insights into MMP-TIMP interactions","volume":"878","author":"Bode","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc.2016.115","article-title":"TIMPs: Versatile extracellular regulators in cancer","volume":"17","author":"Jackson","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1183\/09031936.94.07112062","article-title":"The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis","volume":"7","author":"Ray","year":"1994","journal-title":"Eur. Respir. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2006.08.006","article-title":"MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma","volume":"104","author":"Honkavuori","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Fields, G.B. (2019). Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01278"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/thno.21674","article-title":"Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics","volume":"8","author":"Abdalla","year":"2018","journal-title":"Theranostics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","article-title":"Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy","volume":"15","author":"Ebos","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yu, J., Zhang, Y., Leung, L.-H., Liu, L., Yang, F., and Yao, X. (2016). Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: A systematic review and meta-analysis. J. Hematol. Oncol., 9.","DOI":"10.1186\/s13045-016-0340-8"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16314","DOI":"10.1073\/pnas.1903330116","article-title":"Functional selection of protease inhibitory antibodies","volume":"116","author":"Lopez","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jmb.2013.04.009","article-title":"Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases","volume":"425","author":"Udi","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_96","first-page":"143","article-title":"Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential","volume":"18","author":"Kikkeri","year":"2011","journal-title":"Nat. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Das, N., Benko, C., Gill, S., and Dufour, A. (2020). The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors. Pharmaceuticals, 14.","DOI":"10.20944\/preprints202012.0167.v1"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., and Wang, T. (2021). Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal Transduct. Target. Ther., 6.","DOI":"10.1038\/s41392-021-00572-w"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1158\/1535-7163.MCT-16-0194","article-title":"Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study","volume":"15","author":"Winer","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjc.6600446","article-title":"A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer","volume":"87","author":"Bramhall","year":"2002","journal-title":"Br. J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12472\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:32:32Z","timestamp":1760167952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":100,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222212472"],"URL":"https:\/\/doi.org\/10.3390\/ijms222212472","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]}}}